Skip to main content
Premium Trial:

Request an Annual Quote

IconoClust, Microarray Database of Gene Expression (MADGE)

Premium

Clondiag chip technologies of Jena, Germany, has released IconoClust, an array imaging software that allows automated analysis of both individual array images and groups of array images. The software allows users to import files from an arraying system, such as *.gal files, and to use them. The software includes an image browser that enables rapid import and processing of images. The data processing script for analysis of images can be modified or generated by the user, the company said. The software includes interfaces that can integrate it with other databases including laboratory information management systems. The software is available for download and a free one-month test from the company’s website, http://www.clondiag.com/ ?jump=products. For a fee of $400 or €420, the software can also be licensed for an unlimited time.

Richard McIndoe, a professor of pathology at the University of Florida College of Medicine, and his staff at the department’s microarray facility, have developed a Microarray Database of Gene Expression, (MADGE). The database uses a three-tier client server model. The first tier includes a relational database system, SQL Server v. 7.0. The second layer is an object-oriented data services layer, in the form of a distributed COM server, that enables access to the underlying database tables. The third layer is an internet-based user interface. The system will be available for the academic community to license within a month. Information about MADGE will be available at http://www.genomics.ufl.edu/niddkbtc/ resources/software.htm.

 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.